业务
货币单位:英镑
2023/FY
名称营收比例
The Development of cell-based therapies53万100.00%
地区
货币单位:英镑
2023/FY
名称营收比例
Income associated with development activities39.4万74.34%
特许权使用费收入13.6万25.66%